Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The Biden-Harris administration wants to expand coverage of anti-obesity medications in the Medicare and Medicaid programs.

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

Obesity is associated with increased odds of mood and anxiety disorders, including more serious mental health conditions such as schizophrenia and bipolar disease.

A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...

The Biden administration is proposing to cover drugs like Ozempic, which is used to treat heart disease, diabetes and obesity ...

The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

Popular weight-loss drugs like Wegovy or Ozempic would be covered by Medicare or Medicaid under a newly-proposed rule by the ...

Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...

“Our Medicare and Medicaid populations are some of the most at-risk and they do not have access to any anti-obesity ...

I suspect that the cost of this single executive action will end up exceeding all the savings that DOGE generates put ...